
AI in Healthcare: Diagnostics to Drug Discovery
I'm Rashid Mahmood, Co-founder of Rust Innovation, and AI in healthcare is the field where I feel the stakes most personally. When software gets finance wrong, someone loses money. When it gets healthcare wrong, someone gets hurt. That weight shapes everything I will say here, including the optimism, because the potential is genuinely enormous if we get the deployment right.
The real story of 2026 is not the robot doctor. It is giving caregivers their evenings back.
AI in healthcare diagnostics: the real story
Diagnostics is where AI in healthcare made its name, and the capabilities are real. Medical imaging was the first breakthrough: models that flag potential tumors, fractures, and retinal disease in scans, often catching things tired human eyes miss at 2 a.m. The best deployments work as a second reader, with the radiologist making the final call and the AI making sure nothing slips through.
What changed recently is breadth. Beyond imaging, AI now assists with pathology slides, ECG interpretation, dermatology triage from phone photos, and early warning scores that predict patient deterioration hours before it becomes obvious. None of these replace clinical judgment. All of them extend it, especially in places where specialists are scarce.
Here is the part that matters for the developing world, close to my heart. A rural clinic with one general physician and an AI diagnostic assistant is practicing at a different level than that same clinic alone. It will not fix unequal access by itself, but it is the first technology that scales specialist-level pattern recognition to anywhere with an internet connection. That is a big deal.
Admin automation: the quiet win for AI in healthcare
If diagnostics is the headline, admin automation is the workhorse. Clinical documentation, coding, prior authorization, appointment scheduling, insurance claims: the paperwork burden that burns out healthcare workers worldwide.
Ambient scribes are the standout. An AI scribe listens to the patient visit (with consent), drafts the clinical note, and files it for the doctor to review and sign. The consistent report from physicians using them is the same: evenings back, and note quality that often improves because the scribe captures details a rushed doctor would skip.
Prior authorization is another quiet revolution. The back-and-forth between providers and insurers that delays care for weeks is increasingly handled by AI workflows that assemble the clinical evidence, submit it correctly the first time, and track it. Patients get answers faster. Staff stop playing phone tag. It is deeply unglamorous and enormously valuable.
Drug discovery and AI in healthcare research
On the research side, AI in healthcare is compressing timelines that used to be measured in decades. Protein structure prediction was the watershed: knowing a protein's shape unlocks understanding of how diseases work and where drugs might bind. What took years of lab work now takes computation.
The pipeline effects compound from there. AI models now propose candidate molecules, predict their properties, flag toxicity risks early, and design better clinical trials by identifying the right patient populations. Drug discovery has always been a numbers game with brutal failure rates. AI in healthcare does not change the biology, but it dramatically improves which numbers you play.
I am careful with timelines here. A faster pipeline still means years from candidate to pharmacy shelf, because safety testing cannot and should not be rushed. But more shots on goal, with better aim, is how breakthroughs happen.
The risks nobody should hand-wave
Now the serious part, because AI in healthcare demands more caution than any other field I write about. Biased training data is the top concern. A diagnostic model trained mostly on one population can underperform on others, which means worse care for the people already getting worse care. Every deployment needs validation across diverse populations, not just the data that was convenient.
Privacy is next. Health data is the most sensitive data there is, and AI in healthcare systems need strong guarantees: on-premise or private-cloud deployment, clear data retention policies, no training on patient data without proper consent and anonymization. My advice to healthcare teams is to treat vendor data practices as the first evaluation criterion, before accuracy numbers.
Then liability and trust. When an AI-assisted diagnosis goes wrong, who is responsible? The frameworks are still evolving, which is why keeping the clinician as the final decision-maker is not just good practice but essential risk management. And patients deserve transparency: if AI helped with your diagnosis, you should know.
Where AI in healthcare goes from here
My honest outlook: AI in healthcare in 2026 is past the pilot phase and into the hard work of real deployment. The winners will be the systems that integrate into clinical workflows without adding clicks, that prove their value across diverse patients, and that keep clinicians firmly in charge.
If you run a healthcare organization, start with the burden crushing your people. Documentation, scheduling, authorizations. Prove value there, build trust, then expand toward clinical decision support with proper validation. The technology is ready for much of this. The deployment discipline is what separates success from expensive pilots.
The doctor who leaves on time, rested, present for her patients: that is what this technology is for. Everything else is commentary.